Most infection prevention guidelines center on the hospital environment rather than the patient. But the source of antibiotic-resistant microbes is often from the patient’s own body.
The use of orthopedic implants or tumor necrosis factor inhibitors doubled the risk for bone infections in patients with RA who had contracted S aureus bacteremia.
The U.S. health regulator approved Basilea Pharmaceutica's antibiotic for bacterial infections including multidrug-resistant strains, the FDA said on.